Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

APOA5 Antikörper (AA 20-363)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch APOA5 in WB und ELISA. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN1842850

Kurzübersicht für APOA5 Antikörper (AA 20-363) (ABIN1842850)

Target

Alle APOA5 Antikörper anzeigen
APOA5 (Apolipoprotein A-V (APOA5))

Reaktivität

  • 73
  • 31
  • 26
  • 4
  • 3
  • 3
  • 2
  • 1
Human

Wirt

  • 71
  • 26
  • 2
  • 1
Maus

Klonalität

  • 75
  • 25
  • 1
Monoklonal

Konjugat

  • 60
  • 11
  • 7
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser APOA5 Antikörper ist unkonjugiert

Applikation

  • 69
  • 48
  • 34
  • 23
  • 21
  • 13
  • 7
  • 6
  • 5
  • 4
  • 4
  • 2
  • 1
Western Blotting (WB), ELISA
  • Bindungsspezifität

    • 9
    • 6
    • 6
    • 5
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 20-363

    Aufreinigung

    Purified antibody

    Immunogen

    Purified recombinant fragment of human APOA5 (AA: 20-363) expressed in E. Coli.

    Isotyp

    IgG1
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1.0 mg/mL

    Buffer

    PBS containing 0.03 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
  • Target

    APOA5 (Apolipoprotein A-V (APOA5))

    Andere Bezeichnung

    Apoa5

    Hintergrund

    Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglycerides, whereas a knock-in model with human ApoA5 produced 50-70% lower concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor- agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.

    Molekulargewicht

    41 kDa

    Gen-ID

    116519

    UniProt

    Q6Q788

    Pathways

    Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
Sie sind hier:
Chat with us!